TheCanadaTime

Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants

2026-02-19 - 07:33

About Eupraxia Pharmaceuticals Inc. Read More

Share this post: